-
Mini-Brains Help Spot Schizophrenia and Bipolar Disorder With 92% Accuracy
23 Sep 2025 21:22 GMT
… objective diagnosis and treatment.
Why schizophrenia and bipolar disorder … objective biomarkers. Medications are prescribed by trial and error, … mini-brains that develop multiple types of neural … drugs before treatment begins. That would avoid the current trial …
-
With little proof, Trump links Tylenol to autism and touts a treatment
23 Sep 2025 20:31 GMT
… of disorders including autism and schizophrenia.
What’s more, … opinion, will benefit.”
Widespread treatment of children with this … been no large clinical trials conducted on leucovorin. “ … behind a large, randomized controlled trial, multi-center,” Klatt says …
-
Innovative mental health treatment tech struggles for traction as pharma dominates
23 Sep 2025 10:51 GMT
… severe mental disorders such as schizophrenia and severe depression remain … ons.”
Such companies developing adjunct mental health treatments include Otsuka Precision Health … are in development. In March, Abbott initiated its pivotal trial evaluating the …
-
Treatment Patterns and Outcomes from OASIS: A Prospective Observational Study of Long-Acting Injectables in Schizophrenia
23 Sep 2025 08:49 GMT
… antipsychotic medications were developed to address challenges with treatment … in randomized controlled trials (RCTs).25,26 … LAI antipsychotic medications were effective treatments for schizophrenia with … treated with antipsychotic drugs: results from the …
-
Defence closes, jury to deliberate in Loafers Lodge trial
23 Sep 2025 06:12 GMT
… in the Loafers Lodge murder trial, and the jury will begin … the man - who has schizophrenia and has pleaded not guilty … to managing his illness through medication.
The lies he told - …
-
MapLight Keeps Biopharma’s IPO Flame Alight to Advance Alzheimer’s, Schizophrenia Drugs
22 Sep 2025 12:05 GMT
The biopharma industry is counting its second initial public offering this month, with California-based MapLight Therapeutics announcing a Nasdaq bid with the goal of drumming up support for its pipeline of neuropsychiatric therapies.
MapLight’s initial …
-
FDA turns down Lundbeck, Otsuka's Rexulti in PTSD on lack of efficacy data
23 Sep 2025 02:33 GMT
… FDA to determine the appropriate path forward.”
The current treatment … that one of the trials failed to reach statistical … : major depressive disorder, schizophrenia and agitation associated with … a co-marketing and development collaboration with its now …
-
'Guesswork and speculation': Defence closes in Loafers Lodge trial
23 Sep 2025 01:44 GMT
A lawyer for the man who lit the fatal Loafers Lodge blaze says for the jury to accept the Crown's case, "massive guesswork and speculation" would be involved.
The 50-year-old defendant, whose name is suppressed, is charged with five counts …
-
AI Detects Schizophrenia and Bipolar Disorder Neural Signatures in Organoids
22 Sep 2025 22:21 GMT
… iPSC-Derived Models of Schizophrenia and Bipolar Disorder,” … classification accuracy in distinguishing schizophrenia from control samples in … produced by neurons during development, comparing them to … give patients these drugs, with a trial-and-error method …
-
MapLight lines up an IPO in bid to challenge Bristol Myers schizophrenia drug
22 Sep 2025 21:47 GMT
… developing its lead drug as a potential treatment for schizophrenia … schizophrenia without some of the side effects seen with existing drugs. The FDA … ongoing Alzheimer’s trial are getting thrice daily … results from its schizophrenia trial in 2026 and the …